Rankings
▼
Calendar
SNDX FY 2024 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SNDX
Syndax Pharmaceuticals, Inc.
$2B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$24M
Gross Profit
$23M
96.5% margin
Operating Income
-$340M
-1434.4% margin
Net Income
-$319M
-1346.1% margin
EPS (Diluted)
$-3.73
Cash Flow
Operating Cash Flow
-$275M
Free Cash Flow
-$275M
Stock-Based Comp.
$43M
Balance Sheet
Total Assets
$725M
Total Liabilities
$437M
Stockholders' Equity
$288M
Cash & Equivalents
$154M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$0
—
Gross Profit
$23M
$0
—
Operating Income
-$340M
-$230M
-47.7%
Net Income
-$319M
-$209M
-52.3%
← Q4 2023
All Quarters
Q1 2024 →